Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Vifor Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (9)
Australian public assessment report (AusPar) (7)
Prescription medicine registration (4)
Prescription medicine decision summary (2)
Designation or determination (1)

Date

2023 (5)
2022 (2)
2021 (4)
2020 (1)
2019 (8)
2016 (1)
2015 (1)
2011 (1)

Search

Sponsor content

23 result(s) found, displaying 11 to 20

FERRUM H iron 100mg/2mL (as polymaltose) injection ampoule Cancelled under Section 30(1)(c) of the Act

23 April 2021

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
ESMYA ulipristal acetate 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 October 2020

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
AusPAR: Patiromer sorbitex calcium

4 October 2019

Australian public assessment report (AusPar)

Australian Public Assessment Report for Patiromer sorbitex calcium
PERSKINDOL ACTIVE GEL Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL FORTE GEL Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL ACTIVE FLUID Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL ACTIVE SPRAY Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL FORTE SPRAY Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL COOL SPRAY Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd
PERSKINDOL ACTIVE BATH OIL Cancelled under Section 30(1)(c) of the Act

14 May 2019

Cancellation by sponsor

Requested by Vifor Pharma Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.